Early molecular diagnosis of acute chagas disease after transplantation with organs from Trypanosoma cruzi-infected donors

American Journal of Transplantation

Volumn 13, Issue 12, 2013, Pages 3253-3261

  Cura, C I ^a   Lattes, R ^b   Nagel, C ^c   Gimenez, M J ^d   Blanes, M ^d   Calabuig, E ^d   Iranzo, A ^d   Barcan, L A ^e   Anders, M ^f   Schijman, A G ^a  

^a INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

^b Instituto de Nefrologia Buenos Aires ar   (Argentina)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^f HOSPITAL ALEMÁN   (Argentina)

Author keywords

Extended donor criteria; Genotyping; Infectious diseases; PCR; Transplantation

Indexed keywords

BENZNIDAZOLE; DNA POLYMERASE;

ADULT; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID; CHAGAS DISEASE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; MALE; MOLECULAR DIAGNOSIS; ORGAN DONOR; ORGAN TRANSPLANTATION; PARASITE IDENTIFICATION; PARASITE LOAD; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROLOGY; TRYPANOSOMA CRUZI;

EXTENDED DONOR CRITERIA; GENOTYPING; INFECTIOUS DISEASES; PCR; TRANSPLANTATION;

ADOLESCENT; ADULT; AGED; ALGORITHMS; CHAGAS DISEASE; DNA, KINETOPLAST; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TIME FACTORS; TISSUE DONORS; TRYPANOSOMA CRUZI; YOUNG ADULT;

EID: 84888388771     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12487     Document Type: Article

References (31)

1. World Health Organization. Report of the Scientific Working Group on Chagas disease. Geneva: World Health Organization, 2007, TDR/SWG/09.
2. Storino R, Barragán H., Epidemiología. In:, Storino R, Milei J, editors. Enfermedad de Chagas. Buenos Aires, Argentina: Doyma, 1994, 51-74.
3. Bern C, Montgomery SP., An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009; 49: e52-e54.
4. Jackson Y, Gétaz L, Wolff H, et al. Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. PLoS Negl Trop Dis 2010; 4: e592.
5. Drugs for Neglected Diseases Initiative. Argentina: More action needed. Newsletter 2010; 19: article 5.
6. The Chagas Disease Argentine Collaborative Transplant Consortium and Domingo Casadei. Chagas' disease and solid organ transplantation. Transplant Proc 2010; 42: 3354-3359.
7. McCormack L, Quiñõnez E, Goldaracena N, et al. Liver transplantation using Chagas-infected donors in uninfected recipients: A single-center experience without prophylactic therapy. Am J Transplant 2012; 12: 2832-2837.
8. Pinazo MJ, Miranda B, Rodríguez-Villar C, et al. Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas. Transplant Rev 2011; 25: 91-101.
9. Tibayrenc M, Ward P, Moya A, Ayala F., Natural populations of Trypanosoma cruzi, the agent of Chagas disease, have a complex multiclonal structure. Proc Natl Acad Sci 1986; 83: 115-119.
10. Machado C, Ayala F., Nucleotide sequences provide evidence of genetic exchange among distantly related lineages of Trypanosoma cruzi. Proc Natl Acad Sci 2001; 98: 7396-7401.
11. Zingales B, Andrade SG, Briones MR, et al. A new consensus for Trypanosoma cruzi intraspecific nomenclature: Second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz 2009; 104: 1051-1054.
12. Zingales B, Miles MA, Campbell DA, et al. The revised Trypanosoma cruzi subspecific nomenclature: Rationale, epidemiological relevance and research applications. Infect Genet Evol 2012; 12: 240-253.
13. Duffy T, Bisio M, Altcheh J, et al. Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in Chagas disease patients. PLoS Negl Trop Dis 2009; 3: e419.
14. Duffy T, Cura CI, Ramírez JC, et al. Analytical performance of a multiplex real-time PCR assay using TaqMan probes for quantification of Trypanosoma cruzi satellite DNA in blood samples. PLoS Negl Trop Dis 2013; 7: e2000.
15. Burgos JM, Begher S, Valadares Silva H, et al. Case report: Molecular identification of Trypanosoma cruzi I tropism for central nervous system in Chagas reactivation due to AIDS. Am J Trop Med Hyg 2008; 78: 294-297.
16. Schijman AG, Bisio M, Orellana L, et al. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl Trop Dis 2011; 5: e931.
17. Burgos JM, Altcheh J, Bisio M, et al. Direct molecular characterization of bloodstream parasite populations causing Congenital Chagas disease. Int J Parasitol 2007; 37: 1319-1327.
18. Burgos JM, Diez M, Vigliano C, et al. Molecular identification of Trypanosoma cruzi discrete typing units in end-stage chronic Chagas heart disease and reactivation after heart transplantation. Clin Infect Dis 2010; 51: 485-495.
19. de Faria JB, Alves G., Transmission of Chagas disease through cadaveric renal transplantation. Transplantation 1993; 56: 746-747.
20. Vazquez MC, Riarte A, Pattin M, Lauricella M., Chagas disease can be transmitted through kidney transplantation. Transplant Proc 1993; 25: 3259-3260.
21. Riarte A, Luna C, Sabatiello R, et al. Chagas disease in patients with kidney transplants: 7 years of experience 1989-1996. Clin Infect Dis 1999; 29: 561-567.
22. Barcán L, Luna C, Clara L, et al. Transmission of T. cruzi infection via liver transplantation to a nonreactive recipient for Chagas disease. Liver Transpl 2005; 11: 1112-1116.
23. D'Albuquerque LA, Gonzalez AM, Filho HL, et al. Liver transplantation from deceased donors serologically positive for Chagas disease. Am J Transplant 2007; 7: 680-684.
24. Centers for Disease Control and Prevention. Chagas disease after organ transplantation-United States, 2001. JAMA 2002; 287: 1795-1796.
25. Centers for Disease Control and Prevention. Chagas disease after organ transplantation-Los Angeles, California, 2006. MMWR Morb Mortal Wkly Rep 2006; 55: 798-800.
26. Diez M, Favaloro L, Bertolotti A, et al. Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow-up in heart transplantation. Am J Transplant 2007; 7: 1633-1640.
27. Cura CI, Lucero RH, Bisio M, et al. Trypanosoma cruzi discrete typing units in Chagas disease patients from endemic and non-endemic regions of Argentina. Parasitology 2012; 139: 516-521.
28. Burgos JM, Begher SB, Freitas JM, et al. Molecular diagnosis and typing of Trypanosoma cruzi populations and lineages in cerebral Chagas disease in a patient with AIDS. Am J Trop Med Hyg 2005; 73: 1016-1018.
29. Diosque P, Barnabe C, Padilla A, et al. Multilocus enzyme electrophoresis analysis of Trypanosoma cruzi isolates from a geographically restricted endemic area for Chagas disease in Argentina. Int J Parasitol 2003; 33: 997-1003.
30. Del Puerto R, Nishizawa JE, Kikuchi M, et al. Lineage analysis of circulating Trypanosoma cruzi parasites and their association with clinical forms of Chagas disease in Bolivia. PLoS Negl Trop Dis 2010; 4: e687.
31. Valadares HM, Pimenta JR, de Freitas JM, et al. Genetic profiling of Trypanosoma cruzi directly in infected tissues using nested PCR of polymorphic microsatellites. Int J Parasitol 2008; 38: 839-850.